/**/ document.writeln("\n\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n\n\n\n\n\n\n\n \n\n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
Markets
Quote
Depth/LII
Charts
News
Historical
\n \n\n
\n \n
\n \n \n \n \n \n\n\n\n\n\n\n\n\n
\nSymbol: \n\n\n \nSymbol Lookup | Recent Quotes\n\n\n\n\n
\n\n\n
\n\n\n\n\n		powered by
  quotemedia.com
\n \n
\n \n \n\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n \n\n \n\n
\n\n \n \n \n \n \n \n \n \n \n
Detailed Quote for XenoPort Inc. (XNPT) \n \n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 18.92\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n 0.00\n\n (0.00%)\n\n \n\n \n\n \n\n \n\n Volume: 60.97 k\n\n \n\n \n\n\n\n 11:16 AM EST Feb 10, 2010\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n \n\n \n \n\n\n \n \n \n \n \n \n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n 52 Week Information
\n
\n
52 Week High\n \"\"
\n \n
February 13,2009
\n \n
Close: \n 27.37\n
\n
\n
\n
52 Week Low\n \"\"
\n \n
April 30,2009
\n \n
Close: \n 13.36\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n \n\n \n
\n \n \n\n\n \n \n
\n \n \n \n \n \n
\n \n \n\n\n \n \n \n \n \n \n \n \n\n\n\n \n
Today5d1m3m1ymore
\n\n 		\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n \n \n\n \n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n
\n \n \n \n
Last Price
18.92
\n 		\n\n \n \n \n
Change $
\n \n \n \n
\n 		\n \n\n \n \n
Change %
\n\n \n \n \n
\n 		\n \n \n \n
Tick
\n \n   \n \n
\n
\n \n \n\n \n
Bid
18.92
\n 		\n \n \n \n\n
Bid Size
100
\n 		\n \n \n \n
Ask
18.94
\n\n 		\n \n \n \n
Ask Size
200
\n
\n \n \n \n
Open
18.85
\n 		\n \n \n \n
High
19.08
\n 		\n\n \n \n \n
Low
18.65
\n 		\n \n\n \n \n
Prev Close
18.92
\n
\n \n\n \n \n
Last Trade
11:16
\n 		\n \n \n \n
Volume
60.97 k
\n 		\n \n \n \n
\n
52 Wk Hi
27.37
\n 		\n\n \n \n \n
52 Wk Low
13.36
\n
\n \n\n \n \n
Market Cap
574.04 m
\n 		\n \n \n \n
Ex-Div Date
N/A
\n 		\n \n \n \n \n \n\n
Div Rate
0.00
\n 		\n \n \n \n
Yield
0.00
\n\n
\n \n\n \n \n
Shares
30,340,201
\n 		\n \n \n \n
EPS (TTM)
-2.41
\n 		\n \n \n \n\n
PE Ratio
N/A
\n 		\n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n Exchange Information\n
\n
\n
Listed On
\n \n
Nasdaq Global Select (NGS)
\n
\n
\n
\n
\n
\n \n
Exchange
NGS
\n
\n \n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n \n\n News and Media for XenoPort Inc.\n\n \n\n  (XNPT) \n\n \n\n \n\n\n
\n Sector News | Topic News\n
\n\n
\n
\n
Sector News
\n
Basic Materials
\n
  - Chemicals
\n
  - Energy
\n
  - Metals & Mining
\n
Conglomerates
\n
  - Conglomerates
\n
Consumer Goods
\n
  - Consumer Durables
\n
  - Consumer Non-Durables
\n
  - Automotive
\n
  - Food & Beverage
\n
  - Tobacco
\n
Financial
\n
  - Banking
\n
  - Financial Services
\n
  - Insurance
\n
  - Real Estate
\n
Healthcare
\n
  - Drugs
\n
  - Health Services
\n
Industrial Goods
\n
  - Aerospace/Defense
\n
  - Manufacturing
\n
  - Materials & Construction
\n
Services
\n
  - Leisure
\n
  - Media
\n
  - Retail
\n
  - Specialty Retail
\n
  - Wholesale
\n
  - Diversified Services
\n
  - Transportation
\n
Technology
\n
  - Computer Hardware
\n
  - Computer Software & Services
\n
  - Electronics
\n
  - Telecommunications
\n
  - Internet
\n
Utilities
\n
  - Utilities
\n\n
\n
Hide
\n
\n
\n
\n
Market News
\n\n
AMEX
\n
Nasdaq
\n
NYSE
\n
OTCBB
\n\n
Pink Sheets
\n
Mutual Funds
\n\n
Commodities
\n
TSX
\n\n
World Market News
\n
Asia Pacific
\n\n
Europe
\n
Corporate Actions
\n\n
Stock Buyback
\n
Dividends
\n
Earnings
\n
Stock Splits
\n\n
Insider Trading
\n
IPO's
\n\n
Business & Finance
\n\n
Antitrust
\n
Banking & Finance
\n\n
Capital Gains
\n
Mergers & Acquisitions
\n
Economy
\n\n
Consumer Price Index
\n
Bond/Stock Update
\n\n
Federal Reserve
\n
Foreign Exchange
\n
International Monetary Fund
\n
Interest Rates
\n\n
\n\n
Hide
\n
\n
\n
\n\n
\n\n\n\n \n\n \n\n
\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n
\n\n\n\n \n\n \n\n News for XNPT\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Feb 09, 2010
\n\n \n\n\n\n
4:13 PM\n\n\n\n XenoPort Announces Extension of the Horizant(TM) PDUFA Date to February 11, 2010 - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Feb 04, 2010
\n\n \n\n\n\n
12:39 PM\n\n\n\n XenoPort Announces Horizant(TM) as Brand Name for XP13512 - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Jan 08, 2010
\n\n \n\n\n\n
10:00 AM\n\n\n\n XenoPort to Present at the 28th Annual J.P. Morgan Healthcare Conference - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Nov 19, 2009
\n\n \n\n\n\n
6:30 AM\n\n\n\n Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 for Restless Legs Syndrome - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Nov 06, 2009
\n\n \n\n\n\n
8:15 PM\n\n\n\n GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010 - Business Wire
8:15 PM\n\n\n\n CORRECTING and REPLACING GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010 - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Nov 03, 2009
\n\n \n\n\n\n
4:05 PM\n\n\n\n XenoPort Reports Third Quarter Financial Results - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Oct 29, 2009
\n\n \n\n\n\n
1:30 PM\n\n\n\n XenoPort to Release Third Quarter Financial Results on November 3, 2009 - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Oct 19, 2009
\n\n \n\n\n\n
6:30 AM\n\n\n\n XenoPort Announces Initiation of a Phase 2b Clinical Trial of Arbaclofen Placarbil in Patients with Gastroesophageal Reflux Disease - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Oct 05, 2009
\n\n \n\n\n\n
6:30 AM\n\n\n\n Positive Phase II Results for GSK1838262 (XP13512) Reported for Subjects with Post-Herpetic Neuralgia and a History of Inadequate Response to Gabapentin - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Sep 17, 2009
\n\n \n\n\n\n
6:00 AM\n\n\n\n Positive Phase IIb Results for GSK1838262 (XP13512) Reported for Neuropathic Pain Associated with Post-Herpetic Neuralgia - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Sep 09, 2009
\n\n \n\n\n\n
1:30 PM\n\n\n\n XenoPort to Present at Upcoming Conferences - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Sep 16, 2008
\n\n \n\n\n\n
8:04 AM\n\n\n\n GSK and XenoPort Announce Submission of New Drug Application Requesting FDA Approval of Solzira(TM) for Restless Legs Syndrome - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Apr 17, 2008
\n\n \n\n\n\n
3:15 PM\n\n\n\n Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Nov 10, 2006
\n\n \n\n\n\n
5:52 PM\n\n\n\n /C O R R E C T I O N -- XenoPort, Inc./ - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Sun, Oct 22, 2006
\n\n \n\n\n\n
7:00 PM\n\n\n\n XenoPort Announces Positive Results From XP19986 Phase 2a Trial in Patients with Gastroesophageal Reflux Disease - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Oct 20, 2006
\n\n \n\n\n\n
11:00 AM\n\n\n\n XenoPort to Present at Upcoming Investor Conferences - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Oct 06, 2006
\n\n \n\n\n\n
1:53 PM\n\n\n\n XenoPort to Release Third Quarter Financial Results on November 2, 2006 - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Sep 05, 2006
\n\n \n\n\n\n
1:00 PM\n\n\n\n XenoPort to Present at Upcoming Investor Conferences - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Aug 09, 2006
\n\n \n\n\n\n
4:05 PM\n\n\n\n XenoPort Reports Second Quarter Financial Results - PR Newswire
\n\n More News for XNPT >>
\n\n
\n\n
\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n DL+   Realtime BATS,  \n EOD   End Of Day,  \n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, fundamentals by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");